Association between tamoxifen and tooth loss in women with breast cancer.
Breast cancer
Dental caries
Oral health
Tamoxifen
Tooth extraction
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
06
05
2022
accepted:
29
06
2022
pubmed:
8
7
2022
medline:
28
9
2022
entrez:
7
7
2022
Statut:
ppublish
Résumé
Investigate the effect of tamoxifen on the occurrence of tooth loss (TL) in breast cancer (BC) survivors. A cross-sectional study was conducted with 140 BC survivors using tamoxifen therapy. Sociodemographic, medical, and dental data were evaluated. TL was determined using the M component of the Decayed, Missing and Filled Teeth (DMFT) index. Logistic regression models were run to determine associations between the independent variables and outcome (TL). Mean TL was 12.96 (SD 8.88). Only three participants had lost no teeth and 10.7% were completely edentulous. Participants who used tamoxifen for more than 1 year had a higher mean missing teeth (13.99 vs. 10.45; P = 0.030). After the adjustments, the occurrence of more than 12 missing teeth was 2.75-fold higher among women who used tamoxifen for more than 1 year (95% CI: 1.06-7.12). Moreover, age over 65 years, referral for treatment by the public healthcare system, less use of dental services, xerostomia, and a lower occurrence of dental caries remained associated with the loss of more than 12 teeth. Longer use of tamoxifen was associated with greater tooth loss in breast cancer survivors. Based on estimates of the increase in cases of breast cancer, the prolonged use of tamoxifen for the treatment of this disease can exert an impact on oral health through the occurrence of tooth loss. These findings can contribute to the planning and implementation of oral health care and prevention strategies for such patients.
Identifiants
pubmed: 35796887
doi: 10.1007/s00520-022-07271-4
pii: 10.1007/s00520-022-07271-4
doi:
Substances chimiques
Myeloma Proteins
0
Tamoxifen
094ZI81Y45
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8193-8199Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
GBD 2017 Oral Disorders Collaborators Bernabe E, Marcenes W, Hernandez CR et al (2020) Global regional and national levels and trends in burden of oral conditions from 1990 to 2017 a systematic analysis for the global burden of disease 2017 study. J Dent Res 99(4):362-373. doi: https://doi.org/10.1177/0022034520908533
Houshmand M, Holtfreter B, Berg MH et al (2012) Refining definitions of periodontal disease and caries for prediction models of incident tooth loss. J Clin Periodontol 39(7):635–644. https://doi.org/10.1111/j.1600-051X.2012.01892.x
doi: 10.1111/j.1600-051X.2012.01892.x
pubmed: 22612722
Haag DG, Peres KG, Balasubramanian M et al (2017) Oral conditions and health-related quality of life: a systematic review. J Dent Res 96(8):864–874. https://doi.org/10.1177/0022034517709737
doi: 10.1177/0022034517709737
pubmed: 28581891
Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660
doi: 10.3322/caac.21660
pubmed: 33538338
Harbeck N, Gnant M (2017) Breast cancer. Lancet 389(10074):1134–1150. https://doi.org/10.1016/S0140-6736(16)31891-8
doi: 10.1016/S0140-6736(16)31891-8
pubmed: 27865536
Brinton LA, Gaudet MM, Gierach GL (2018) Breast cancer, cancer epidemiology and prevention p. 861–888.
Łukasiewicz S, Czeczelewski M, Forma A et al (2021) Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review. Cancers (Basel) 13(17):4287. https://doi.org/10.3390/cancers13174287
doi: 10.3390/cancers13174287
Runowicz CD, Leach CR, Henry NL et al (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin 66(1):43–73. https://doi.org/10.3322/caac.21319
doi: 10.3322/caac.21319
pubmed: 26641959
Epstein JB, Thariat J, Bensadoun RJ et al (2012) Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin 62(6):400–422. https://doi.org/10.3322/caac.21157
doi: 10.3322/caac.21157
pubmed: 22972543
Jardim LC, Flores PT, de Araujo SF et al (2019) Oral lesions and associated factors in breast cancer survivors. J Investig Clin Dent 10(4):e12447. https://doi.org/10.1111/jicd.12447
doi: 10.1111/jicd.12447
pubmed: 31402601
Jardim LC, Flores PT, do Carmo Dos Santos Araújo M et al (2020) Oral health-related quality of life in breast cancer survivors. Support Care Cancer 28(1):65–71. https://doi.org/10.1007/s00520-019-04792-3
doi: 10.1007/s00520-019-04792-3
pubmed: 30982094
Ustaoğlu G, Bulut DG, Üyetürk U et al (2021) Evaluation of periodontal health in breast cancer patients undergoing tamoxifen or aromatase inhibitors drugs therapy a cross-sectional study. Spec Care Dentist Jan; 41(1):41–48
doi: 10.1111/scd.12538
Hong CH, Napeñas JJ, Hodgson BD et al (2010) A systematic review of dental disease in patients undergoing cancer therapy. Support Care Cancer 18(8):1007–1021. https://doi.org/10.1007/s00520-010-0873-2
doi: 10.1007/s00520-010-0873-2
pubmed: 20449756
pmcid: 2914291
Taichman LS, Van Poznak CH, Inglehart MR (2016) Self-reported oral health and quality of life of postmenopausal breast cancer survivors on aromatase inhibitors and women without cancer diagnoses: a longitudinal analysis. Support Care Cancer 24(11):4815–4824. https://doi.org/10.1007/s00520-016-3336-6
doi: 10.1007/s00520-016-3336-6
pubmed: 27455851
pmcid: 5614704
World Health Organization (1997) Oral health surveys. Basic Methods. Geneva: World Health Organization :93.
Nowjack-Raymer RE, Sheiham A (2007) Numbers of natural teeth, diet, and nutritional status in US adults. J Dent Res 86(12):1171–1175. https://doi.org/10.1177/154405910708601206
doi: 10.1177/154405910708601206
pubmed: 18037650
Chen QL, Zeng XT, Luo ZX et al (2016) Tooth loss is associated with increased risk of esophageal cancer: evidence from a meta-analysis with dose-response analysis. Sci Rep 6:18900. https://doi.org/10.1038/srep18900
Shi J, Leng W, Zhao L et al (2017) Tooth loss and cancer risk a dose-response meta analysis of prospective cohort studies. Oncotarget 9(19):15090–15100. https://doi.org/10.18632/oncotarget.23850
doi: 10.18632/oncotarget.23850
pubmed: 29599929
pmcid: 5871100
Loos BG (2005) Systemic markers of inflammation in periodontitis. J Periodontol 76(11 Suppl):2106–2115. https://doi.org/10.1902/jop.2005.76.11-S.2106
doi: 10.1902/jop.2005.76.11-S.2106
pubmed: 16277583
Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860–867. https://doi.org/10.1038/nature01322
doi: 10.1038/nature01322
pubmed: 12490959
pmcid: 2803035
Zhang HP, Cao HY, Yuan AH (2013) The principle and progress of anti-inflammation treatment of gastric cancer. Modern Medical Journal 41(8):605–609
Shi T, Min M, Sun C et al (2018) Periodontal disease and susceptibility to breast cancer: a meta-analysis of observational studies. J Clin Periodontol 45(9):1025–1033. https://doi.org/10.1111/jcpe.12982
doi: 10.1111/jcpe.12982
pubmed: 29974484
Waks AG, Winer EP (2019) Breast cancer treatment: a review. JAMA 321(3):288–300. https://doi.org/10.1001/jama.2018.19323
doi: 10.1001/jama.2018.19323
pubmed: 30667505
Davies C, Pan H, Godwin J et al (2013) Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial [published correction appears in Lancet Mar 9;381(9869):804. doi: https://doi.org/10.1016/S0140-6736(12)61963-1 .
Mahesh DR, Komali G, Jayanthi K et al (2014) Evaluation of salivary flow rate, pH and buffer in pre, post & post nenopausal women on HRT. J Clin Diagn Res. 8(2):233–6. https://doi.org/10.7860/JCDR/2014/8158.4067
doi: 10.7860/JCDR/2014/8158.4067
Taichman LS, Havens AM, Van Poznak CH (2013) Potential implications of adjuvant endocrine therapy for the oral health of postmenopausal women with breast cancer. Breast Cancer Res Treat 137(1):23–32. https://doi.org/10.1007/s10549-012-2217-z
doi: 10.1007/s10549-012-2217-z
pubmed: 22986813
Taichman LS, Gomez G, Inglehart MR (2015) Oral health-related complications of breast cancer treatment: assessing dental hygienists’ knowledge and professional practice. J Dent Hyg 89(Suppl 2):22–37
pubmed: 26338905
pmcid: 5614710
Pedersen AML, Sørensen CE, Proctor GB (2018) Salivary secretion in health and disease. J Oral Rehabil 45(9):730–746
doi: 10.1111/joor.12664
Välimaa H, Savolainen S, Soukka T (2004) Estrogen receptor-beta is the predominant estrogen receptor subtype in human oral epithelium and salivary glands. J Endocrinol. 180(1):55–62. https://doi.org/10.1677/joe.0.1800055
doi: 10.1677/joe.0.1800055
pubmed: 14709144
Lucisano MP, da Silva RAB, de Sousa Pereira AP (2021) Alteration of the oral microbiota may be a responsible factor, along with estrogen deficiency, by the development of larger periapical lesions. Clin Oral Investig Jun. 25(6):3651–3662. https://doi.org/10.1007/s00784-020-03688-5
doi: 10.1007/s00784-020-03688-5
Streckfus CF, Baur U, Brown LJ et al (1998) Effects of estrogen status and aging on salivary flow rates in healthy Caucasian women. Gerontology 44(1):32–39. https://doi.org/10.1159/000021980
doi: 10.1159/000021980
pubmed: 9436013
Mosel DD, Bauer RL, Lynch DP et al (2011) Oral complications in the treatment of cancer patients. Oral Dis 17(6):550–559. https://doi.org/10.1111/j.1601-0825.2011.01788.x
doi: 10.1111/j.1601-0825.2011.01788.x
pubmed: 21306481
Kim S, Park S, Lin M (2017) Permanent tooth loss and sugar-sweetened beverage intake in U.S. young adults. J Public Health Dent. 77(2):148–154. https://doi.org/10.1111/jphd.12192
doi: 10.1111/jphd.12192
pubmed: 27886383
Matos DL, Lima-Costa MF, Guerra HL (2002) Bambuí Project: an evaluation of private, public and unionized dental services. Rev Saude Publica 36(2):237–243. https://doi.org/10.1590/s0034-89102002000200017
doi: 10.1590/s0034-89102002000200017
pubmed: 12045806
Unfer B, Saliba O (2000) Evaluate of popular knowledge and everyday practices in oral health. Rev Saude Publica 34(2):190–195. https://doi.org/10.1590/s0034-89102000000200014
doi: 10.1590/s0034-89102000000200014
pubmed: 10881156
Srivastava P, Chen G, Harris A (2017) Oral health, dental insurance and dental service use in Australia. Health Econ 26(1):35–53. https://doi.org/10.1002/hec.3272
doi: 10.1002/hec.3272
pubmed: 26449483